Of note, co-expression of CD103, PD-1 and CD39 has been recently shown to identify a Tres subset characterized by a distinct transcriptional signature of tumor-specific antigen responder T cells in solid tumors [245]. This evidence concerns the gene PDCD1 and neoplasm.